Literature DB >> 33578013

Antibiotic stewardship in direct-to-consumer telemedicine consultations leads to high adherence to best practice guidelines and a low prescription rate.

Carlos H S Pedrotti1, Tarso A D Accorsi2, Karine De Amicis Lima2, Ary Serpa Neto3, Maria T S de S Lira2, Renata A Morbeck2, Eduardo Cordioli2.   

Abstract

OBJECTIVE: To analyze the antibiotic prescription rate in low-risk patients evaluated at a telemedicine program that adopts antibiotic stewardship protocols.
METHODS: Adult patients who accessed a single direct-to-consumer telemedicine center (Jan/2019-Feb/2020) were retrospectively enrolled. Diseases amenable to antimicrobial treatment were classified under five diagnostic groups: upper respiratory tract infection (URI), acute pharyngotonsillitis (PT), acute sinusitis (AS), urinary tract infection (UTI), and acute diarrhea (AD). Physicians were trained on and advised to strictly follow the current guideline recommendations supported by institutional antibiotic stewardship protocols, readily available online during consultations. We analyzed the antibiotic prescription rate among patients, referral rate, and antibiotic class through descriptive statistics.
RESULTS: A total of 2328 patients were included in the study. A total of 2085 (89·6%) patients were discharged with usual recommendations, medication (if needed), and instructions about red flags, while 243 (10·4%) were referred to a face-to-face consultation. Among the discharged patients, the antibiotic prescription rates by the diagnostic group were URI - 2·5%, PT - 35·0%, AS - 51·8%, UTI - 91.6%, and AD - 1·6%. In most cases, prescribed antibiotics were in line with institutional stewardship protocols.
CONCLUSIONS: Low prescription rate of antibiotics can be achieved using antibiotic stewardship protocols at direct-to-consumer telemedicine consultations, showing high adherence to international guidelines. These results reinforce telemedicine as a cost-effective and safe strategy for the initial assessment of acute non-urgent symptoms.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Antibacterial agents; Communicable diseases; Infectious disease medicine; Practice guideline; Telemedicine

Year:  2021        PMID: 33578013     DOI: 10.1016/j.ijid.2021.02.020

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  2 in total

1.  Telemedicine diagnosis of acute respiratory tract infection patients is not inferior to face-to-face consultation: a randomized trial.

Authors:  Tarso Augusto Duenhas Accorsi; Flavio Tocci Moreira; Carlos Henrique Sartorato Pedrotti; Karine De Amicis; Renata Farias Vidigal Correia; Renata Albaladejo Morbeck; Fernanda Ferreira Medeiros; José Leão de Souza; Eduardo Cordioli
Journal:  Einstein (Sao Paulo)       Date:  2022-05-27

Review 2.  Opportunities and challenges in improving antimicrobial use during the era of telehealth expansion: A narrative review.

Authors:  Hiroyuki Suzuki; Stephanie C Shealy; Kyle Throneberry; Edward Stenehjem; Daniel Livorsi
Journal:  Antimicrob Steward Healthc Epidemiol       Date:  2021-10-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.